載入...
Treatment Selection Choices Should Not Be Based on Benefits or Costs Alone: A Head-to-Head Randomized Controlled Trial of Antiviral Drugs for Hepatitis C.
Clinicians often face dilemmas with decisions related to formulary choices when two similar drugs are simultaneously available in the market. We studied the comparative safety, effectiveness, and treatment costs of the two first generation direct-acting antiviral agents (DAA), boceprevir and telapre...
Na minha lista:
Main Authors: | , , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
Public Library of Science (PLoS)
2016-01-01
|
叢編: | PLoS ONE |
在線閱讀: | http://europepmc.org/articles/PMC5065164?pdf=render |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|